AlphaFold predicted structure
AR · P10275

Mean pLDDT
57.3/ 100
Low
920 residues
Confidence breakdown
- Very high(≥ 90)27%
- Confident(70–90)11%
- Low(50–70)4%
- Very low(< 50)58%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
androgen receptor
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesDifferences in sex development
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesFetal anomalies
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesAdult onset neurodegenerative disorder
OtherAmyotrophic lateral sclerosis/motor neuron disease
OtherEctodermal dysplasia
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesFamilial breast cancer
Familial Meniere Disease
+3 more panels — install the extension to see the full list inline on any page.
androgen insensitivity syndrome
partial androgen insensitivity syndrome
prostate cancer
Kennedy disease
prostate carcinoma
neoplasm
hypogonadism
prostate adenocarcinoma
Familial prostate cancer
hypogonadotropic hypogonadism
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Androgen receptor
Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues (PubMed:19022849). Transcription factor activity is modulated by bound coactivator and corepressor proteins like ZBTB7A that recruits NCOR1 and NCOR2 to the androgen response elements/ARE on target genes, negatively regulating androgen receptor signaling and androgen-induced cell proliferation (PubMed:20812024). Transcription activation is also down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3
Curated MONDO disease pages that list AR among their top associated genes.
AR · P10275

Mean pLDDT
57.3/ 100
Low
920 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0